|
1
|
Anderson ME: Update on survival in
osteosarcoma. Orthop Clin North Am. 47:283–292. 2016. View Article : Google Scholar
|
|
2
|
Poletajew S, Fus L and Wasiutyński A:
Current concepts on pathogenesis and biology of metastatic
osteosarcoma tumors. Ortop Traumatol Rehabil. 13:537–545. 2011.
View Article : Google Scholar
|
|
3
|
Maximov VV and Aqeilan RI: Genetic factors
conferring metastasis in osteosarcoma. Future Oncol. 12:1623–1644.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dyson N: The regulation of E2F by
pRB-family proteins. Genes Dev. 12:2245–2262. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee JS, Leem SH, Lee SY, Kim SC, Park ES,
Kim SB, Kim SK, Kim YJ, Kim WJ and Chu IS: Expression signature of
E2F1 and its associated genes predict superficial to invasive
progression of bladder tumors. J Clin Oncol. 28:2660–2667. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alla V, Engelmann D, Niemetz A, Pahnke J,
Schmidt A, Kunz M, Emmrich S, Steder M, Koczan D and Pützer BM:
E2F1 in melanoma progression and metastasis. J Natl Cancer Inst.
102:127–133. 2010. View Article : Google Scholar
|
|
7
|
Liang YX, Lu JM, Mo RJ, He HC, Xie J,
Jiang FN, Lin ZY, Chen YR, Wu YD, Luo HW, et al: E2F1 promotes
tumor cell invasion and migration through regulating CD147 in
prostate cancer. Int J Oncol. 48:1650–1658. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rammal H, Saby C, Magnien K, Van-Gulick L,
Garnotel R, Buache E, El Btaouri H, Jeannesson P and Morjani H:
Discoidin domain receptors: Potential actors and targets in cancer.
Front Pharmacol. 7:552016.PubMed/NCBI
|
|
9
|
Miao L, Zhu S, Wang Y, Li Y, Ding J, Dai
J, Cai H, Zhang D and Song Y: Discoidin domain receptor 1 is
associated with poor prognosis of non-small cell lung cancer and
promotes cell invasion via epithelial-to-mesenchymal transition.
Med Oncol. 30:6262013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Koh M, Woo Y, Valiathan RR, Jung HY, Park
SY, Kim YN, Kim HR, Fridman R and Moon A: Discoidin domain receptor
1 is a novel transcriptional target of ZEB1 in breast epithelial
cells undergoing H-Ras-induced epithelial to mesenchymal
transition. Int J Cancer. 136:E508–E520. 2015. View Article : Google Scholar
|
|
11
|
Shimada K, Nakamura M, Ishida E, Higuchi
T, Yamamoto H, Tsujikawa K and Konishi N: Prostate cancer antigen-1
contributes to cell survival and invasion though discoidin receptor
1 in human prostate cancer. Cancer Sci. 99:39–45. 2008.
|
|
12
|
Huo Y, Yang M, Liu W, Yang J, Fu X, Liu D,
Li J, Zhang J, Hua R and Sun Y: High expression of DDR1 is
associated with the poor prognosis in Chinese patients with
pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res. 34:882015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xie R, Wang X, Qi G, Wu Z, Wei R, Li P and
Zhang D: DDR1 enhances invasion and metastasis of gastric cancer
via epithelial-mesenchymal transition. Tumour Biol. 37:12049–12059.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pagliarini V, Giglio P, Bernardoni P, De
Zio D, Fimia GM, Piacentini M and Corazzari M: Downregulation of
E2F1 during ER stress is required to induce apoptosis. J Cell Sci.
128:1166–1179. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shats I, Gatza ML, Liu B, Angus SP, You L
and Nevins JR: FOXO transcription factors control E2F1
transcriptional specificity and apoptotic function. Cancer Res.
73:6056–6067. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Summy JM and Gallick GE: Src family
kinases in tumor progression and metastasis. Cancer Metastasis Rev.
22:337–358. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Valencia K, Ormazabal C, Zandueta C,
Luis-Ravelo D, Antó I, Pajares MJ, Agorreta J, Montuenga LM,
Martínez-Canarias S, Leitinger B, et al: Inhibition of collagen
receptor discoidin domain receptor-1 (DDR1) reduces cell survival,
homing, and colonization in lung cancer bone metastasis. Clin
Cancer Res. 18:969–980. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Engelmann D and Pützer BM: The dark side
of E2F1: In transit beyond apoptosis. Cancer Res. 72:571–575. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Meng P and Ghosh R: Transcription
addiction: Can we garner the Yin and Yang functions of E2F1 for
cancer therapy? Cell Death Dis. 5:e13602014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ahn JD, Kim CH, Magae J, Kim YH, Kim HJ,
Park KK, Hong S, Park KG, Lee IK and Chang YC: E2F decoy
oligodeoxynucleotides effectively inhibit growth of human tumor
cells. Biochem Biophys Res Commun. 310:1048–1053. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liontos M, Niforou K, Velimezi G, Vougas
K, Evangelou K, Apostolopoulou K, Vrtel R, Damalas A,
Kontovazenitis P, Kotsinas A, et al: Modulation of the E2F1-driven
cancer cell fate by the DNA damage response machinery and potential
novel E2F1 targets in osteosarcomas. Am J Pathol. 175:376–391.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Russo AJ, Magro PG, Hu Z, Li WW, Peters R,
Mandola J, Banerjee D and Bertino JR: E2F-1 overexpression in U2OS
cells increases cyclin B1 levels and cdc2 kinase activity and
sensitizes cells to antimitotic agents. Cancer Res. 66:7253–7260.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stevens C, Smith L and La Thangue NB: Chk2
activates E2F-1 in response to DNA damage. Nat Cell Biol.
5:401–409. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Galbiati L, Mendoza-Maldonado R, Gutierrez
MI and Giacca M: Regulation of E2F-1 after DNA damage by
p300-mediated acetylation and ubiquitination. Cell Cycle.
4:930–939. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao Y, Li H, Ma X, Fan Y, Ni D, Zhang Y,
Huang Q, Liu K, Li X, Wang L, et al: KLF6 suppresses metastasis of
clear cell renal cell carcinoma via transcriptional repression of
E2F1. Cancer Res. 77:330–342. 2017. View Article : Google Scholar
|
|
26
|
Engelmann D, Mayoli-Nüssle D, Mayrhofer C,
Fürst K, Alla V, Stoll A, Spitschak A, Abshagen K, Vollmar B, Ran
S, et al: E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3
axis in a feedback loop for cooperative induction of PDGF-B. J Mol
Cell Biol. 5:391–403. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sharma A, Yeow WS, Ertel A, Coleman I,
Clegg N, Thangavel C, Morrissey C, Zhang X, Comstock CE, Witkiewicz
AK, et al: The retinoblastoma tumor suppressor controls androgen
signaling and human prostate cancer progression. J Clin Invest.
120:4478–4492. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu Y, Liu J, Jiang B, Chen J, Fu Z, Bai F,
Jiang J and Tang Z: MiR-199a-5p loss up-regulated DDR1 aggravated
colorectal cancer by activating epithelial-to-mesenchymal
transition related signaling. Dig Dis Sci. 59:2163–2172. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shintani Y, Fukumoto Y, Chaika N, Svoboda
R, Wheelock MJ and Johnson KR: Collagen I-mediated up-regulation of
N-cadherin requires cooperative signals from integrins and
discoidin domain receptor 1. J Cell Biol. 180:1277–1289. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gao H, Chakraborty G, Zhang Z, Akalay I,
Gadiya M, Gao Y, Sinha S, Hu J, Jiang C, Akram M, et al:
Multi-organ site metastatic reactivation mediated by non-canonical
discoidin domain receptor 1 signaling. Cell. 166:47–62. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gialeli C, Theocharis AD and Karamanos NK:
Roles of matrix metalloproteinases in cancer progression and their
pharmacological targeting. FEBS J. 278:16–27. 2011. View Article : Google Scholar
|
|
32
|
Juin A, Di Martino J, Leitinger B, Henriet
E, Gary AS, Paysan L, Bomo J, Baffet G, Gauthier-Rouvière C,
Rosenbaum J, et al: Discoidin domain receptor 1 controls linear
invadosome formation via a Cdc42-Tuba pathway. J Cell Biol.
207:517–533. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang SH, Baek HA, Lee HJ, Park HS, Jang
KY, Kang MJ, Lee DG, Lee YC, Moon WS and Chung MJ: Discoidin domain
receptor 1 is associated with poor prognosis of non-small cell lung
carcinomas. Oncol Rep. 24:311–319. 2010.PubMed/NCBI
|
|
34
|
Castro-Sanchez L, Soto-Guzman A,
Guaderrama-Diaz M, Cortes-Reynosa P and Salazar EP: Role of DDR1 in
the gelatinases secretion induced by native type IV collagen in
MDA-MB-231 breast cancer cells. Clin Exp Metastasis. 28:463–477.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hidalgo-Carcedo C, Hooper S, Chaudhry SI,
Williamson P, Harrington K, Leitinger B and Sahai E: Collective
cell migration requires suppression of actomyosin at cell-cell
contacts mediated by DDR1 and the cell polarity regulators Par3 and
Par6. Nat Cell Biol. 13:49–58. 2011. View
Article : Google Scholar :
|
|
36
|
Ram R, Lorente G, Nikolich K, Urfer R,
Foehr E and Nagavarapu U: Discoidin domain receptor-1a (DDR1a)
promotes glioma cell invasion and adhesion in association with
matrix metalloproteinase-2. J Neurooncol. 76:239–248. 2006.
View Article : Google Scholar
|
